Search Results - "Goodnature, Barbara"

Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer by Ingle, James N., Kalari, Krishna R., Barman, Poulami, Shepherd, Lois E., Ellis, Matthew J., Goss, Paul E., Buzdar, Aman U., Robson, Mark E., Cairns, Junmei, Carlson, Erin E., Eyman Casey, Abraham, Hoskin, Tanya L., Goodnature, Barbara A., Haddad, Tufia C., Goetz, Matthew P., Weinshilboum, Richard M., Wang, Liewei

“…OBJECTIVESBased on our previous findings that postmenopausal women with estrone (E1) and estradiol (E2) concentrations at or above 1.3 pg/ml and 0.5 pg/ml,…”
Get full text

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action by Cairns, Junmei, Ingle, James N, Dudenkov, Tanda M, Kalari, Krishna R, Carlson, Erin E, Na, Jie, Buzdar, Aman U, Robson, Mark E, Ellis, Matthew J, Goss, Paul E, Shepherd, Lois E, Goodnature, Barbara, Goetz, Matthew P, Weinshilboum, Richard M, Li, Hu, Bari, Mehrab Ghanat, Wang, Liewei

“…Aromatase inhibitors (AIs) reduce breast cancer recurrence and prolong survival, but up to 30% of patients exhibit recurrence. Using a genome-wide association…”
Get full text

Evaluation of Vertebroplasty with a Validated Outcome Measure: The Roland-Morris Disability Questionnaire by Trout, Andrew T, Kallmes, David F, Gray, Leigh A, Goodnature, Barbara A, Everson, Sandra L, Comstock, Bryan A, Jarvik, Jeffrey G

“…Vertebroplasty is rapidly disseminating as a treatment for vertebral compression fractures, but its efficacy has not been assessed with a well-validated, back…”
Get full text

Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial by Haddad, Tufia C, Suman, Vera J, Giridhar, Karthik V, Sideras, Kostandinos, Northfelt, Donald W, Ernst, Brenda J, O'Sullivan, Ciara C, Singh, Ravinder J, Desta, Zeruesenay, Peethambaram, Prema P, Hobday, Timothy J, Chumsri, Saranya, Leon-Ferre, Roberto A, Ruddy, Kathryn J, Yadav, Siddhartha, Taraba, Jodi L, Goodnature, Barbara, Goetz, Matthew P, Wang, Liewei, Ingle, James N

“…We previously reported that postmenopausal women with estrogen receptor-α-positive breast cancer receiving adjuvant anastrozole 1 mg/day (ANA1) with estrone…”
Get full text

Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α by Ingle, James N, Cairns, Junmei, Suman, Vera J, Shepherd, Lois E, Fasching, Peter A, Hoskin, Tanya L, Singh, Ravinder J, Desta, Zeruesenay, Kalari, Krishna R, Ellis, Matthew J, Goss, Paul E, Chen, Bingshu E, Volz, Bernhard, Barman, Poulami, Carlson, Erin E, Haddad, Tufia, Goetz, Matthew P, Goodnature, Barbara, Cuellar, Matthew E, Walters, Michael A, Correia, Cristina, Kaufmann, Scott H, Weinshilboum, Richard M, Wang, Liewei

“…To determine if the degree of estrogen suppression with aromatase inhibitors (AI: anastrozole, exemestane, letrozole) is associated with efficacy in…”
Get full text

Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early‐Stage Breast Cancer by Cairns, Junmei, Kalari, Krishna R., Ingle, James N., Shepherd, Lois E., Ellis, Matthew J., Goss, Paul E., Barman, Poulami, Carlson, Erin E., Goodnature, Barbara, Goetz, Matthew P., Weinshilboum, Richard M., Gao, Huanyao, Wang, Liewei

“…Aromatase inhibitors (AIs) are the treatment of choice for hormone receptor–positive early breast cancer in postmenopausal women. None of the third‐generation…”
Get full text

SNP biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer by Ingle, James N., Kalari, Krishna R., Barman, Poulami, Shepherd, Lois E., Ellis, Matthew J., Goss, Paul E., Buzdar, Aman U., Robson, Mark E., Cairns, Junmei, Carlson, Erin E., Casey, Abraham Eyman, Hoskin, Tanya L., Goodnature, Barbara A., Haddad, Tufia C., Goetz, Matthew P., Weinshilboum, Richard M., Wang, Liewei

Get full text

Abstract OT1-04-02: Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early stage breast cancer: A prospective trial by Haddad, Tufia C., Suman, Vera, Giridhar, Karthik V., Moreno-Aspitia, Alvaro, Northfelt, Donald, Ernst, Brenda, Sideras, Kostandinos, O’Sullivan, Ciara C., Singh, Ravinder, Desta, Zeruesenay, Taraba, Jodi, Goodnature, Barbara, Goetz, Matthew P., Wang, Liewei, Ingle, James N.

“…Abstract Introduction: We performed matched case-control studies utilizing cohorts of postmenopausal women with ER+ breast cancer receiving adjuvant aromatase…”
Get full text